Signal Boost: Real-World Evidence Fits US FDA’s Safety Ambitions More Easily Than Efficacy

RWE is already transforming the US FDA’s active surveillance systems and could catalyze change in pregnancy postmarketing studies, but is advancing more slowly for use as efficacy evidence.